MedTrace Logo

DNA Methylation and the Increased Risk of Cervical Cancer Development

NCT06859151 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-03-05

No results posted yet for this study

Summary

This study aims to investigate the correlation between reproductive tract microbiota and DNA methylation in cervical epithelial cells, as well as its impact on the development of cervical cancer, through a paired case-control clinical study

Conditions

Interventions

OTHER

Reproductive tract microbiota

Reproductive tract microbiota

Sponsors & Collaborators

  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • Muxuan Chen, Doctor · Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-20
Primary Completion
2025-12-30
Completion
2026-12-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06859151 on ClinicalTrials.gov